Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

SVRA | Savara Inc

Index	RUT	P/E	-	EPS (ttm)	-0.28	Insider Own	37.52%	Shs Outstand	114.05M	Perf Week	0.00%
Market Cap	510.94M	Forward P/E	-	EPS next Y	-0.29	Insider Trans	7.28%	Shs Float	84.45M	Perf Month	0.80%
Income	-42.69M	PEG	-	EPS next Q	-0.07	Inst Own	34.77%	Short Float / Ratio	3.49% / 5.55	Perf Quarter	18.31%
Sales	0.00M	P/S	-	EPS this Y	-15.20%	Inst Trans	2.93%	Short Interest	2.95M	Perf Half Y	85.29%
Book/sh	0.77	P/B	4.92	EPS next Y	-0.69%	ROA	-30.86%	Target Price	4.60	Perf Year	147.06%
Cash/sh	0.78	P/C	4.86	EPS next 5Y	-	ROE	-39.75%	52W Range	1.08 - 4.21	Perf YTD	143.87%
Dividend	-	P/FCF	-	EPS past 5Y	32.33%	ROI	-37.47%	52W High	-10.21%	Beta	0.87
Dividend %	-	Quick Ratio	18.33	Sales past 5Y	-20.00%	Gross Margin	-	52W Low	250.00%	ATR	0.15
Employees	28	Current Ratio	18.33	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	53.56	Volatility	3.42% 4.06%
Optionable	Yes	Debt/Eq	0.30	EPS Q/Q	-24.83%	Profit Margin	-	Rel Volume	0.62	Prev Close	3.78
Shortable	Yes	LT Debt/Eq	0.30	Earnings	Aug 10 AMC	Payout	-	Avg Volume	531.11K	Price	3.78
Recom	1.00	SMA20	0.84%	SMA50	3.10%	SMA200	43.33%	Volume	328,300	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-16-23	Upgrade	Jefferies	Hold → Buy	$2 → $4
Mar-31-23	Downgrade	Jefferies	Buy → Hold	$2
Mar-16-21	Initiated	Piper Sandler	Overweight	$7
Mar-15-21	Initiated	Oppenheimer	Outperform	$4
Jun-13-19	Reiterated	H.C. Wainwright	Buy	$22 → $6
Jun-13-19	Downgrade	Ladenburg Thalmann	Buy → Neutral	$21 → $3
Jun-13-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Aug-13-18	Resumed	ROTH Capital	Neutral	$12
Jan-03-18	Initiated	Ladenburg Thalmann	Buy	$35
Sep-27-17	Resumed	ROTH Capital	Buy	$40
Sep-22-17	Initiated	Jefferies	Buy	$20
Sep-11-17	Initiated	JMP Securities	Mkt Outperform	$20

Show Previous Ratings

Sep-17-23 10:54AM	15 Penny Stocks with Biggest Upside (Insider Monkey)
Sep-12-23 09:12AM	The 3 Best Penny Stocks to Buy Now: September 2023 (InvestorPlace)
Sep-05-23 04:05PM	Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference (Business Wire)
Aug-10-23 04:05PM	Savara Reports Second Quarter Financial Results and Provides Business Update (Business Wire)
Aug-04-23 04:05PM	Savara Announces New Employment Inducement Grant (Business Wire)
07:00AM	Loading…
Jul-13-23 07:00AM	Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants (Business Wire) +8.92%
Jun-26-23 04:05PM	Savara Added to Russell 3000® Index (Business Wire) -7.34%
08:05AM	Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (Business Wire)
Jun-02-23 08:05AM	Savara to Present at the Jefferies Healthcare Conference (Business Wire)
May-28-23 08:26AM	Independent Director of Savara David Ramsay Buys 4.8% More Shares \ (Simply Wall St.)
May-16-23 12:32PM	Why Shares of Savara Jumped on Tuesday (Motley Fool) +9.09%
May-15-23 08:05AM	Savara Reports First Quarter Financial Results and Provides Business Update (Business Wire)
May-05-23 04:05PM	Savara Announces New Employment Inducement Grant (Business Wire) +6.84%
Apr-03-23 07:33AM	Savara Inc. (NASDAQ:SVRA) Is Expected To Breakeven In The Near Future (Simply Wall St.) -6.15%
Mar-31-23 04:05PM	Savara Announces New Employment Inducement Grant (Business Wire)
04:05PM	Loading…
Mar-30-23 04:05PM	Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update (Business Wire)
Mar-20-23 06:35AM	Daily Vickers Top Insider Picks for 03/20/2023 (Argus Research)
Mar-17-23 06:47AM	Daily Vickers Top Insider Picks for 03/17/2023 (Argus Research) -7.31%
Mar-16-23 06:51AM	Daily Vickers Top Insider Picks for 03/16/2023 (Argus Research)
Mar-15-23 06:44AM	Daily Vickers Top Insider Picks for 03/15/2023 (Argus Research)
Mar-13-23 06:32AM	Daily Vickers Top Insider Picks for 03/13/2023 (Argus Research)
Mar-10-23 07:04AM	Daily Vickers Top Insider Picks for 03/10/2023 (Argus Research) -15.94%
Mar-09-23 06:33AM	Daily Vickers Top Insider Picks for 03/09/2023 (Argus Research)
Mar-08-23 06:30AM	Daily Vickers Top Insider Picks for 03/08/2023 (Argus Research)
Mar-07-23 06:34AM	Daily Vickers Top Insider Picks for 03/07/2023 (Argus Research)
Mar-06-23 04:05PM	Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference (Business Wire)
07:22AM	Daily Vickers Top Insider Picks for 03/06/2023 (Argus Research)
Mar-03-23 06:38AM	Daily Vickers Top Insider Picks for 03/03/2023 (Argus Research) -7.42%
Mar-02-23 06:44AM	Daily Vickers Top Insider Picks for 03/02/2023 (Argus Research)
Mar-01-23 06:01AM	Daily Vickers Top Insider Picks for 03/01/2023 (Argus Research)
04:05PM	Loading…
Feb-28-23 04:05PM	Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
06:43AM	Daily Vickers Top Insider Picks for 02/28/2023 (Argus Research)
Feb-27-23 06:50AM	Daily Vickers Top Insider Picks for 02/27/2023 (Argus Research)
Feb-23-23 07:21AM	Daily Vickers Top Insider Picks for 02/23/2023 (Argus Research)
Feb-22-23 06:56AM	Daily Vickers Top Insider Picks for 02/22/2023 (Argus Research)
Feb-21-23 07:35AM	Daily Vickers Top Insider Picks for 02/21/2023 (Argus Research)
Feb-17-23 06:27AM	Daily Vickers Top Insider Picks for 02/17/2023 (Argus Research)
Feb-16-23 07:28AM	Daily Vickers Top Insider Picks for 02/16/2023 (Argus Research)
Feb-15-23 07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research) +6.52%
06:24AM	Savara Inc. (NASDAQ:SVRA) insiders placed bullish bets worth US$858k in the last 12 months (Simply Wall St.)
Feb-14-23 08:05AM	Savara Announces New Leadership Appointments (Business Wire)
06:23AM	Daily Vickers Top Insider Picks for 02/14/2023 (Argus Research)
Feb-13-23 07:30AM	Daily Vickers Top Insider Picks for 02/13/2023 (Argus Research)
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research)
Feb-09-23 06:51AM	Daily Vickers Top Insider Picks for 02/09/2023 (Argus Research)
Feb-08-23 06:45AM	Daily Vickers Top Insider Picks for 02/08/2023 (Argus Research) -5.16%
Feb-07-23 06:46AM	Daily Vickers Top Insider Picks for 02/07/2023 (Argus Research)
Feb-06-23 06:56AM	Daily Vickers Top Insider Picks for 02/06/2023 (Argus Research)
Feb-03-23 06:32AM	Daily Vickers Top Insider Picks for 02/03/2023 (Argus Research)
Feb-02-23 06:43AM	Daily Vickers Top Insider Picks for 02/02/2023 (Argus Research) -5.20%
Feb-01-23 06:14AM	Daily Vickers Top Insider Picks for 02/01/2023 (Argus Research)
Jan-31-23 06:50AM	Daily Vickers Top Insider Picks for 01/31/2023 (Argus Research)
Jan-30-23 06:42AM	Daily Vickers Top Insider Picks for 01/30/2023 (Argus Research)
Jan-27-23 03:47PM	Why Shares of Savara Soared This Week (Motley Fool)
07:00AM	Daily Vickers Top Insider Picks for 01/27/2023 (Argus Research)
Jan-26-23 06:44AM	Daily Vickers Top Insider Picks for 01/26/2023 (Argus Research)
Jan-25-23 06:39AM	Daily Vickers Top Insider Picks for 01/25/2023 (Argus Research) +8.02%
Jan-24-23 06:48AM	Daily Vickers Top Insider Picks for 01/24/2023 (Argus Research) +8.72%
Jan-23-23 06:58AM	Daily Vickers Top Insider Picks for 01/23/2023 (Argus Research)
Jan-20-23 08:05AM	Savara Announces New Employment Inducement Grant (Business Wire)
06:55AM	Daily Vickers Top Insider Picks for 01/20/2023 (Argus Research)
Jan-19-23 06:43AM	Daily Vickers Top Insider Picks for 01/19/2023 (Argus Research)
Jan-18-23 06:28AM	Daily Vickers Top Insider Picks for 01/18/2023 (Argus Research)
Jan-17-23 06:27AM	Daily Vickers Top Insider Picks for 01/17/2023 (Argus Research)
Jan-13-23 06:56AM	Daily Vickers Top Insider Picks for 01/13/2023 (Argus Research)
Jan-12-23 06:50AM	Daily Vickers Top Insider Picks for 01/12/2023 (Argus Research)
Jan-11-23 06:53AM	Daily Vickers Top Insider Picks for 01/11/2023 (Argus Research)
Jan-09-23 06:31AM	Daily Vickers Top Insider Picks for 01/09/2023 (Argus Research)
Jan-06-23 06:49AM	Daily Vickers Top Insider Picks for 01/06/2023 (Argus Research)
Jan-05-23 05:43AM	Private equity firms are Savara Inc.'s (NASDAQ:SVRA) biggest owners and were rewarded after market cap rose by US$25m last week (Simply Wall St.)
Jan-04-23 06:54AM	Daily Vickers Top Insider Picks for 01/04/2023 (Argus Research) +9.38%
06:54AM	Daily Vickers Top Buyers & Sellers for 01/04/2023 (Argus Research)
Jan-03-23 06:26AM	Daily Vickers Top Insider Picks for 01/03/2023 (Argus Research)
Dec-30-22 07:17AM	Daily Vickers Top Insider Picks for 12/30/2022 (Argus Research)
Dec-29-22 06:51AM	Daily Vickers Top Insider Picks for 12/29/2022 (Argus Research)
Dec-27-22 07:11AM	Daily Vickers Top Insider Picks for 12/27/2022 (Argus Research)
Dec-23-22 06:32AM	Daily Vickers Top Insider Picks for 12/23/2022 (Argus Research)
Nov-22-22 04:05PM	Savara Announces New Employment Inducement Grant (Business Wire)
Nov-10-22 04:05PM	Savara Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Nov-09-22 04:05PM	Savara to Participate in Three Upcoming Investor Conferences (Business Wire)
Sep-14-22 04:05PM	Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Sep-06-22 04:05PM	Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022 (Business Wire)
Sep-03-22 08:16AM	Trade Alert: The Independent Director Of Savara Inc. (NASDAQ:SVRA), David Ramsay, Has Just Spent US$142k Buying 6.2% More Shares (Simply Wall St.)
Sep-01-22 08:05AM	Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference (Business Wire)
Aug-26-22 08:05AM	Savara Announces Resignation of Chief Medical Officer (Business Wire) -10.63%
Aug-25-22 08:05AM	Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (Business Wire)
Aug-11-22 04:05PM	Savara Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Jul-28-22 01:43PM	What Kind Of Investors Own Most Of Savara Inc. (NASDAQ:SVRA)? (Simply Wall St.)
Jul-11-22 08:05AM	Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022 (Business Wire)
06:19AM	Zacks.com featured highlights include Savara, The LGL Group, and Harte Hanks (Zacks)
Jul-08-22 07:10AM	3 Top Breakout Stocks to Add to Your Portfolio Now (Zacks) +8.77%
Jun-17-22 09:40AM	Has Assertio (ASRT) Outpaced Other Medical Stocks This Year? (Zacks)
Jun-16-22 08:05AM	Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic (Business Wire)
Jun-13-22 12:33PM	Bullish insiders bet US$837k on Savara Inc. (NASDAQ:SVRA) (Simply Wall St.)
Jun-01-22 04:05PM	Savara to Present at Jefferies Healthcare Conference (Business Wire)
May-23-22 09:55AM	After Golden Cross, Savara Inc. (SVRA)'s Technical Outlook is Bright (Zacks)
May-17-22 04:05PM	Savara to Present at H.C. Wainwright Global Investment Conference (Business Wire)
May-11-22 04:05PM	Savara Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-05-22 09:00AM	Examining Penny Stocks with Technical Analysis for May 2022 (Investopedia) -5.74%
Apr-29-22 11:16AM	Is Savara (NASDAQ:SVRA) A Risky Investment? (Simply Wall St.)

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yang Rick	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:13 PM
SANDELL SCOTT D	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:11 PM
Walker Paul Edward	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:12 PM
Mathers Edward T	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:10 PM
Makhzoumi Mohamad	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:09 PM
Florence Anthony A. Jr.	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:08 PM
Chang Carmen	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:07 PM
Behbahani Ali	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:06 PM
BASKETT FOREST	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:05 PM
Growth Equity Opportunities 17	10% Owner	Jul 17	Buy	3.00	333,333	999,999	24,471,264	Jul 19 07:04 PM
Pratt Raymond Dennis	Chief Medical Officer	Jun 26	Buy	2.93	6,500	19,045	160,000	Jun 27 07:00 AM
RAMSAY DAVID A	Director	May 26	Buy	2.63	37,124	97,599	2,201,142	May 26 11:31 AM
RAMSAY DAVID A	Director	May 25	Buy	2.57	12,876	33,130	2,164,018	May 26 11:31 AM
RAMSAY DAVID A	Director	May 24	Buy	2.56	50,000	127,800	2,151,142	May 26 11:31 AM
RAMSAY DAVID A	Director	Dec 30	Buy	1.55	29,000	44,834	2,101,142	Jan 03 12:41 PM
RAMSAY DAVID A	Director	Dec 29	Buy	1.54	7,000	10,752	2,072,142	Jan 03 12:41 PM
RAMSAY DAVID A	Director	Dec 28	Buy	1.50	3,293	4,923	2,065,142	Dec 28 04:40 PM
RAMSAY DAVID A	Director	Dec 23	Buy	1.44	15,707	22,665	2,061,849	Dec 28 04:40 PM
RAMSAY DAVID A	Director	Dec 22	Buy	1.48	41,414	61,127	2,046,142	Dec 22 03:19 PM
Pratt Raymond Dennis	Chief Medical Officer	Dec 22	Buy	1.54	3,500	5,402	153,500	Dec 22 03:22 PM
RAMSAY DAVID A	Director	Dec 20	Buy	1.50	13,830	20,759	2,001,142	Dec 20 01:29 PM
RAMSAY DAVID A	Director	Dec 20	Buy	1.48	3,586	5,307	2,004,728	Dec 22 03:19 PM
RAMSAY DAVID A	Director	Dec 19	Buy	1.49	40,719	60,834	1,987,312	Dec 20 01:29 PM
RAMSAY DAVID A	Director	Dec 16	Buy	1.50	341	512	1,946,593	Dec 20 01:29 PM
Elam Nevan C	Director	Dec 13	Option Exercise	0.65	1,172	762	29,244	Dec 15 04:07 PM
Hawkins Richard J	Director	Dec 07	Option Exercise	0.65	1,172	762	1,900	Dec 08 05:08 PM
RAMSAY DAVID A	Director	Nov 23	Buy	1.44	4,610	6,634	1,946,252	Nov 25 08:30 AM
RAMSAY DAVID A	Director	Nov 22	Buy	1.42	15,495	22,018	1,941,642	Nov 25 08:30 AM
RAMSAY DAVID A	Director	Nov 21	Buy	1.42	25,005	35,532	1,926,147	Nov 21 04:39 PM
RAMSAY DAVID A	Director	Nov 18	Buy	1.34	16,100	21,606	1,901,142	Nov 21 04:39 PM
RAMSAY DAVID A	Director	Nov 17	Buy	1.27	8,900	11,303	1,885,042	Nov 21 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SVRA | Savara Inc

Upgrade your FINVIZ experience